Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Magnesium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Paclitaxel-induced Neuropathy 1 Obesity 1 Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Hirsutism 1 Dyslipidemias 1 Agnosia 1 AML 1

Interventions

Bupivacaine 9 Ketamine 8 Analgesics, Opioid 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Oxycodone 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111848 2021-03-02

Magnesium and Ketamine in Postoperative Analgesia

National Cancer Institute, Egypt

Phase 4 Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡